表紙
市場調査レポート

ロシアにおけるオーソバイオロジクス市場の見通し

Russia Orthobiologics Market Outlook to 2021

発行 GlobalData 商品コード 297081
出版日 ページ情報 英文 46 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
ロシアにおけるオーソバイオロジクス市場の見通し Russia Orthobiologics Market Outlook to 2021
出版日: 2015年09月11日 ページ情報: 英文 46 Pages
概要

当レポートでは、ロシアにおけるオーソバイオロジクス市場について、代用骨移植片、関節内補充薬、自家骨移植片、骨成長刺激装置のカテゴリー別売上、販売数の実績および予測、平均価格、企業シェア、流通シェア、主要企業のプロファイル、パイプライン製品、主な財務取引についての最新情報などを提供しまとめており、概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

  • レポートの内容
  • オーソバイオロジクス市場の区分
  • 本レポートで対象としている市場の定義

第3章 ロシアにおけるオーソバイオロジクス市場

  • 収益(実績)
  • 収益(予測)
  • 販売数(実績)
  • 販売数(予測)
  • 平均価格
  • 流通シェア:収益別
  • 企業シェア:収益別

第4章 主要企業の概要

  • DePuy Companies
  • Biomet, Inc.
  • Medtronic, Inc.
  • Orthofix International N.V.
  • Baxter International Inc.
  • Smith & Nephew Plc
  • Stryker Corporation
  • Wright Medical Group, Inc
  • Ferring International Center S.A.

第5章 パイプライン製品

第6章 財務取引の情勢

  • 資本取引
  • 提携

第7章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDMECC1157DB

GlobalData's new report, "Russia Orthobiologics Market Outlook to 2021", provides key market data on the Russia Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Bone Graft and Substitutes, Viscosupplementation and Bone Growth Stimulators.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Orthobiologics market categories - Bone Graft and Substitutes, Viscosupplementation and Bone Growth Stimulators.
  • Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Orthobiologics market.
  • Global corporate-level profiles of key companies operating within the Russia Orthobiologics market.
  • Key players covered include DePuy Companies, Sanofi, Medtronic, Inc., NuVasive, Inc., Biomet, Inc., Smith & Nephew Plc, Baxter International Inc., Wright Medical Group, Inc. and Stryker Corporation.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Orthobiologics Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Orthobiologics Market, Russia

  • 3.1. Orthobiologics Market, Russia, Revenue ($m), 2007-2014
  • 3.2. Orthobiologics Market, Russia, Revenue ($m), 2014-2021
    • 3.2.1. Bone Grafts and Substitutes Market, Russia, Revenue ($m), by Segment, 2007-2014
    • 3.2.2. Bone Grafts and Substitutes Market, Russia, Revenue ($m), by Segment, 2014-2021
  • 3.3. Orthobiologics Market, Russia, Volume (Units), 2007-2014
  • 3.4. Orthobiologics Market, Russia, Volume (Units), 2014-2021
    • 3.4.1. Bone Grafts and Substitutes Market, Russia, Volume (Units), by Segment, 2007-2014
    • 3.4.2. Bone Grafts and Substitutes Market, Russia, Volume (Units), by Segment, 2014-2021
  • 3.5. Orthobiologics Market, Russia, Average Price ($), 2007-2021
  • 3.6. Orthobiologics Market, Russia, Distribution Share by Revenue ($m), 2013-2014
  • 3.7. Orthobiologics Market, Russia, Company Share by Revenue ($m), 2014

4. Overview of Key Companies in Russia, Orthobiologics Market

  • 4.1. DePuy Companies
    • 4.1.1. Company Overview
  • 4.2. Medtronic plc
    • 4.2.1. Company Overview
  • 4.3. Baxter International Inc.
    • 4.3.1. Company Overview
  • 4.4. DJO Finance LLC
    • 4.4.1. Company Overview
  • 4.5. curasan AG
    • 4.5.1. Company Overview
  • 4.6. Bloomage Freda Biopharm Co., Ltd
    • 4.6.1. Company Overview
  • 4.7. Ito Co., Ltd.
    • 4.7.1. Company Overview
  • 4.8. Ferring International Center S.A.
    • 4.8.1. Company Overview
  • 4.9. Stryker Corporation
    • 4.9.1. Company Overview
  • 4.10. Fidia farmaceutici S.p.A.
    • 4.10.1. Company Overview
  • 4.11. Foretek Microsystem Co., Ltd.
    • 4.11.1. Company Overview
  • 4.12. Integra LifeSciences Holdings Corporation
    • 4.12.1. Company Overview
  • 4.13. Sanofi
    • 4.13.1. Company Overview
  • 4.14. Ossatec Benelux B.V.
    • 4.14.1. Company Overview
  • 4.15. Wright Medical Group, Inc.
    • 4.15.1. Company Overview
  • 4.16. Patterson Medical Holdings, Inc.
    • 4.16.1. Company Overview
  • 4.17. Biopore Surgicals Private Limited
    • 4.17.1. Company Overview
  • 4.18. Orthofix International N.V.
    • 4.18.1. Company Overview

5. Orthobiologics Market Pipeline Products

6. Appendix

  • 6.1. Research Methodology
    • 6.1.1. Coverage
    • 6.1.2. Secondary Research
    • 6.1.3. Primary Research
    • 6.1.4. Market Modeling and Forecasting
    • 6.1.5. Company Share Analysis
    • 6.1.6. Distribution Share Analysis
  • 6.2. Expert Panel
  • 6.3. GlobalData Consulting
  • 6.4. Contact Us
  • 6.5. Disclaimer

List of Tables

  • Table 1: Orthobiologics Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 2: Orthobiologics Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 3: Bone Grafts and Substitutes Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 4: Bone Grafts and Substitutes Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 5: Orthobiologics Market, Russia, Volume (Units), Historic, 2007-2014
  • Table 6: Orthobiologics Market, Russia, Volume (Units), Forecast, 2014-2021
  • Table 7: Bone Grafts and Substitutes Market, Russia, Volume (Units), Historic, 2007-2014
  • Table 8: Bone Grafts and Substitutes Market, Russia, Volume (Units), Forecast, 2014-2021
  • Table 9: Orthobiologics Market, Russia, Average Price ($) Historic, 2007-2014
  • Table 10: Orthobiologics Market, Russia, Average Price ($), Forecast, 2014-2021
  • Table 11: Orthobiologics Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 12: Orthobiologics Market, Russia, Company Share by Revenue ($m), USD Constant, 2014
  • Table 13: Orthobiologics Market Pipeline Products
  • Table 14: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country

List of Figures

  • Figure 1: Orthobiologics Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 2: Orthobiologics Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 3: Bone Grafts and Substitutes Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 4: Bone Grafts and Substitutes Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 5: Orthobiologics Market, Russia, Volume (Units), Historic, 2007-2014
  • Figure 6: Orthobiologics Market, Russia, Volume (Units), Forecast, 2014-2021
  • Figure 7: Bone Grafts and Substitutes Market, Russia, Volume (Units), Historic, 2007-2014
  • Figure 8: Bone Grafts and Substitutes Market, Russia, Volume (Units), Forecast, 2014-2021
  • Figure 9: Orthobiologics Market, Russia, Company Share (%) 2014
  • Figure 10: GlobalData Epidemiology-Based Forecasting Model
  • Figure 11: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 12: Primary Interviews by Participant Type (%)
Back to Top